PCV56 PERSISTENCE WITH NEWLY-INITIATED EXTENDED-RELEASE NIACIN VERSUS OTHER LIPID MODIFYING DRUG CLASSES IN CLINICAL PRACTICE
May 1, 2006, 00:00
10.1016/S1098-3015(10)64724-9
https://www.valueinhealthjournal.com/article/S1098-3015(10)64724-9/fulltext
Title :
PCV56 PERSISTENCE WITH NEWLY-INITIATED EXTENDED-RELEASE NIACIN VERSUS OTHER LIPID MODIFYING DRUG CLASSES IN CLINICAL PRACTICE
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)64724-9&doi=10.1016/S1098-3015(10)64724-9
First page :
Section Title :
Open access? :
No
Section Order :
135